The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Retirement planning is essential for achieving financial stability in your later years. Learn why it's never too early to start planning.
21,478 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Investors woke up to another sharp move in a small-cap space contractor. This article breaks down why intuitive machi...
Astera Labs stands at an inflection point: rapid AI demand could lift the stock, but margin pressures and a premium v...
Before you invest in a stock, ask three essential questions. This guide offers a practical framework to assess busine...
Micron stock has surged dramatically, but savvy investors are asking: is it still a bargain? This article breaks down...
JetBlue Airways sparked a rally as reports surfaced about a strategic review, including a possible sale. Here’s what ...
Geopolitics just accelerated volatility in energy markets. The rejection of a ceasefire proposal by iran has traders ...
Cathie Wood built a name on bold bets in disruptive tech. This piece breaks down how ARK Innovation rode dramatic swi...
Occidental Petroleum leads the 2026 performance among three top U.S. energy explorers, with EOG Resources and ConocoP...
Advantage (ADV) stunned some on the street with the Q2 2025 numbers, while others saw a path to steady growth. This d...
If federal foreclosure protections vanish, the housing market could see a surge of distressed properties. This articl...
Keystone reveals a sizable new stake in the IDEF defense ETF, signaling growing investor interest in defense and indu...